Fractyl Laboratories
Ejecutivos
Ver el organigrama con sus 16 ejecutivos principales
Biografías más buscadas en Fractyl Laboratories
- Harith Rajagopalan, Chief Executive Officer and Director
- Allan Will, Chairman of the Board
- Kelly Barnes, Director
Recientes movimientos de ejecutivos en Fractyl Laboratories
- Timothy Kieffer, se ha incorporado a la empresa como Chief Scientific Officer (noticia publicada el 17 de septiembre de 2023).
Crear su alerta
para seguir los movimientos de los ejecutivos en Fractyl Laboratories.
Biotecnología
Fractyl Laboratories tiene 2.292 competidores entre los que se incluyen Eurofins (Luxemburgo), Lonza (Suiza) y Adaptive Phage Therapeutics (Estados Unidos).
Popular M&A news in Biotecnología
- Lycia Therapeutics acaba de anunciar una recaudación de fondos de 107 millones de dólares. (publicado el 15 de mayo de 2024).
- Attovia Therapeutics acaba de anunciar una recaudación de fondos de 150 millones de dólares. (publicado el 14 de mayo de 2024).
- Bruker has announced the acquisition of NanoString Technologies (publicado el 13 de mayo de 2024).
Otros contactos sugeridos en el sector Biotecnología
Noticias
Últimos comunicados de prensa de Fractyl Laboratories
- Fractyl Health Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference and the German Diabetes Association (DDG) Annual Meeting | Fractyl Health, Inc.
- Fractyl Health Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update | Fractyl Health, Inc.
- Fractyl Health Receives FDA IDE Approval for the Revita® Remain-1 Pivotal Study of Weight Maintenance in Obesity after Discontinuation of GLP-1 Based Drugs | Fractyl Health, Inc.
- Fractyl Health Expands Leadership with Appointment of Adrian Kimber as Chief Commercial Officer to Spearhead Anticipated Launch Preparation as the Company Conducts Two Pivotal Studies for Revita in Obesity and Type 2 Diabetes | Fractyl Health, Inc.
- Fractyl Health Announces New Results From Its Rejuva® Platform Demonstrating Potent and Durable Effects of a Single Dose of a Human GLP-1 Pancreatic Gene Therapy Transgene Compared to Semaglutide in the db/db Mouse Model of Diabetes and Obesity | Fractyl
- Fractyl Health Appoints Samuel Conaway to Its Board of Directors, Bolstering New Product Commercial Expertise During Revita® Pivotal Clinical Trials | Fractyl Health, Inc.
- Fractyl Health Announces Nomination of RJVA-001 as First Clinical Candidate in it's Rejuva® GLP-1 Gene Therapy Platform | Fractyl Health, Inc.
- Events & Presentations | Fractyl Health, Inc.
- Fractyl Health Announces Pricing of Initial Public Offering | Fractyl Health, Inc.
- In the News | Fractyl Health, Inc.
- View more press releases Close
Redes sociales sobre Fractyl Laboratories
- Fractyl Laboratories en Wikipedia, Google News y Yahoo Finance
- Fractyl Laboratories en LinkedIn, Twitter y YouTube
Ponerse en contacto
Contactar a través de e-mail con sus ejecutivos Harith Rajagopalan 
Llame a Fractyl Laboratories al +1 781...
